Form D filings with the SEC list Karl Gustav Johan Jungdalen Lundgren as a Director for Impilo Orphan Drugs AB. See sector focus.
Form D filings with the SEC list Karl Gustav Johan Jungdalen Lundgren as a Director for Impilo Orphan Drugs AB. The entity is associated with one offering, Impilo Orphan Drugs AB, which is categorized under the Pooled Investment Fund industry group. The issuer address on file is Stockholm.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Stockholm.
Investors like Karl Gustav Johan Jungdalen Lundgren · Full investor directory · Investor access · Company funding database